NH1 News Debates


Oct 28, 2015 6:05 PM

Warning: Sanofi recalls all injectors used for allergic reactions

The Associated Press

BRIDGEWATER, N.J.— Sanofi is recalling hundreds of thousands of epinephrine injectors used to treat severe allergic reactions - they may not deliver the correct amount of the life-saving drug.

The recall includes all Auvi-Q injections currently on the U.S. market, or roughly 490,000 packs of the devices, the company said in a press release. Most packs include two injectors.

Sanofi's product competes with Mylan's EpiPen, which is a staple of first-aid care. Both products are used to treat allergic reactions caused by insect bites and stings, foods, medicines or other substances.

About 200,000 people in the U.S. have Sanofi's injector, according to company estimates.

The French drug and vaccine maker said it has received 26 reports of malfunctions with the injectors. None involved patient deaths, according to the company announcement.

Consumers can call 1-866-726-6340 or visit the product's website for information on how to return the injector. They should also contact their health provider to get a prescription for an alternate device.

"As this is a life-saving device, it is important that consumers understand not only to return the recalled device, but to get a replacement epinephrine auto-injector first," said a company spokeswoman in an emailed statement.


--  Dealing with the Disease of Addiction? Click here for help --

More from NH1.com

NH1 News Debates
NH1 News Replay

NH1 on Twitter

NH1 SkyView Cameras

NH1 on Facebook

Check out NH1 News Rail Polls on LockerDome on LockerDome